Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916822761> ?p ?o ?g. }
- W2916822761 abstract "To describe the clinical role of CDK 4/6 inhibitors in hormone receptor-positive (HR+) metastatic breast cancer (HR+ MBC) as well as current controversies and evolving areas of research. Palbociclib, ribociclib, and abemaciclib are each approved in combination with an aromatase inhibitor or fulvestrant for HR+ MBC. Abemaciclib is also approved as monotherapy for pre-treated patients. Key questions in the field include whether all patients with HR+ MBC should receive a CDK 4/6 inhibitor up front versus later line, impact on overall survival, role of continued CDK 4/6 blockade, mechanism of clinical resistance, and treatment sequencing. The development of CDK 4/6 inhibitors has changed the therapeutic management of HR+ MBC. Additional research is needed to determine optimal treatment sequencing, understand mechanisms governing resistance, and develop novel therapeutic strategies to circumvent or overcome clinical resistance and further improve the outcomes of patients with MBC." @default.
- W2916822761 created "2019-03-02" @default.
- W2916822761 creator A5007607833 @default.
- W2916822761 creator A5018738915 @default.
- W2916822761 creator A5025351031 @default.
- W2916822761 creator A5034972183 @default.
- W2916822761 date "2019-02-26" @default.
- W2916822761 modified "2023-10-13" @default.
- W2916822761 title "CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions" @default.
- W2916822761 cites W1464936406 @default.
- W2916822761 cites W1709607181 @default.
- W2916822761 cites W18756793 @default.
- W2916822761 cites W1985389450 @default.
- W2916822761 cites W1991601194 @default.
- W2916822761 cites W1999330214 @default.
- W2916822761 cites W2017402038 @default.
- W2916822761 cites W2029080338 @default.
- W2916822761 cites W2042617555 @default.
- W2916822761 cites W2057272791 @default.
- W2916822761 cites W2066788470 @default.
- W2916822761 cites W2084602777 @default.
- W2916822761 cites W2086451010 @default.
- W2916822761 cites W2116159991 @default.
- W2916822761 cites W2137177885 @default.
- W2916822761 cites W2144790402 @default.
- W2916822761 cites W2148345265 @default.
- W2916822761 cites W2150081723 @default.
- W2916822761 cites W2155609574 @default.
- W2916822761 cites W2167188058 @default.
- W2916822761 cites W2171192921 @default.
- W2916822761 cites W2290950904 @default.
- W2916822761 cites W2309969893 @default.
- W2916822761 cites W2474699717 @default.
- W2916822761 cites W2528767298 @default.
- W2916822761 cites W2537675006 @default.
- W2916822761 cites W2552099557 @default.
- W2916822761 cites W2558360748 @default.
- W2916822761 cites W2592406193 @default.
- W2916822761 cites W2617437931 @default.
- W2916822761 cites W2620993107 @default.
- W2916822761 cites W2624068231 @default.
- W2916822761 cites W2741680738 @default.
- W2916822761 cites W2750328162 @default.
- W2916822761 cites W2763875663 @default.
- W2916822761 cites W2767600184 @default.
- W2916822761 cites W2771397989 @default.
- W2916822761 cites W2804105316 @default.
- W2916822761 cites W2805575723 @default.
- W2916822761 cites W2889802486 @default.
- W2916822761 cites W2892043300 @default.
- W2916822761 cites W2896846857 @default.
- W2916822761 cites W3043082495 @default.
- W2916822761 doi "https://doi.org/10.1007/s11912-019-0769-3" @default.
- W2916822761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6573012" @default.
- W2916822761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30806829" @default.
- W2916822761 hasPublicationYear "2019" @default.
- W2916822761 type Work @default.
- W2916822761 sameAs 2916822761 @default.
- W2916822761 citedByCount "111" @default.
- W2916822761 countsByYear W29168227612019 @default.
- W2916822761 countsByYear W29168227612020 @default.
- W2916822761 countsByYear W29168227612021 @default.
- W2916822761 countsByYear W29168227612022 @default.
- W2916822761 countsByYear W29168227612023 @default.
- W2916822761 crossrefType "journal-article" @default.
- W2916822761 hasAuthorship W2916822761A5007607833 @default.
- W2916822761 hasAuthorship W2916822761A5018738915 @default.
- W2916822761 hasAuthorship W2916822761A5025351031 @default.
- W2916822761 hasAuthorship W2916822761A5034972183 @default.
- W2916822761 hasBestOaLocation W29168227612 @default.
- W2916822761 hasConcept C121608353 @default.
- W2916822761 hasConcept C124320809 @default.
- W2916822761 hasConcept C126322002 @default.
- W2916822761 hasConcept C143998085 @default.
- W2916822761 hasConcept C2775930923 @default.
- W2916822761 hasConcept C2776166826 @default.
- W2916822761 hasConcept C2778504769 @default.
- W2916822761 hasConcept C2779744173 @default.
- W2916822761 hasConcept C2780482068 @default.
- W2916822761 hasConcept C29537977 @default.
- W2916822761 hasConcept C530470458 @default.
- W2916822761 hasConcept C71924100 @default.
- W2916822761 hasConcept C84606932 @default.
- W2916822761 hasConcept C98274493 @default.
- W2916822761 hasConceptScore W2916822761C121608353 @default.
- W2916822761 hasConceptScore W2916822761C124320809 @default.
- W2916822761 hasConceptScore W2916822761C126322002 @default.
- W2916822761 hasConceptScore W2916822761C143998085 @default.
- W2916822761 hasConceptScore W2916822761C2775930923 @default.
- W2916822761 hasConceptScore W2916822761C2776166826 @default.
- W2916822761 hasConceptScore W2916822761C2778504769 @default.
- W2916822761 hasConceptScore W2916822761C2779744173 @default.
- W2916822761 hasConceptScore W2916822761C2780482068 @default.
- W2916822761 hasConceptScore W2916822761C29537977 @default.
- W2916822761 hasConceptScore W2916822761C530470458 @default.
- W2916822761 hasConceptScore W2916822761C71924100 @default.
- W2916822761 hasConceptScore W2916822761C84606932 @default.
- W2916822761 hasConceptScore W2916822761C98274493 @default.
- W2916822761 hasFunder F4320337351 @default.
- W2916822761 hasIssue "3" @default.